Back |
home / stock / cnat / cnat message board
Subject | By | Source | When |
---|---|---|---|
* * $CNAT Video Chart 04-18-2019 * * | ClayTrader | investorshub | 04/18/2019 9:26:15 PM |
Look at the link, best of EASL 2019, | lorema | investorshub | 04/18/2019 1:58:56 PM |
Why? | Giovanni | investorshub | 04/18/2019 1:51:07 PM |
Out of hundreds of companies presenting and 2800 | lorema | investorshub | 04/17/2019 12:35:57 AM |
If you look at all the summary slides | fishhunter | investorshub | 04/16/2019 2:34:40 PM |
From EASL 2019 https://ilc-congress.eu/congress-news/ilc-daily-news-saturday-rec | lorema | investorshub | 04/16/2019 5:28:20 AM |
* * $CNAT Video Chart 04-15-2019 * * | ClayTrader | investorshub | 04/15/2019 9:57:43 PM |
I dunno but market over reacted to this | Castisos0 | investorshub | 04/15/2019 9:26:09 PM |
In 2016, few months after Tobira failed to | lorema | investorshub | 04/15/2019 9:12:55 PM |
The fact that it was accepted as a | lorema | investorshub | 04/15/2019 9:04:43 PM |
It was previously announced Dec 5, 2018. | fishhunter | investorshub | 04/15/2019 8:27:59 PM |
Its four month old data. They missed the | weeblewobble09 | investorshub | 04/15/2019 7:26:29 PM |
News, Short Squeeze, Breakout and More Instantly...
Conatus Pharmaceuticals Company Name:
CNAT Stock Symbol:
NASDAQ Market:
Conatus Pharmaceuticals Website:
SAN DIEGO, May 18, 2020 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT) today announced that Institutional Shareholder Services Inc. (ISS) and Glass Lewis, two leading independent research and proxy advisory firms that provide institutional investors with voting assessment an...
SAN DIEGO, May 14, 2020 (GLOBE NEWSWIRE) -- Histogen Inc., a regenerative medicine company with a novel biological platform that replaces and regenerates tissues in the body, announced today the publication of data on HST 004, its patented, naturally-derived material for spinal disc repair ...
SAN DIEGO, May 11, 2020 (GLOBE NEWSWIRE) -- Histogen Inc., a regenerative medicine company with a novel biological platform that replaces and regenerates tissues in the body, announced today that the U.S. Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) app...